TIANSHUI ZHONGXING BIO-TECHNOLOGY CO.,LTD. Financials Tianshui Zhongxing Bio-technology Co.,Ltd.
Equities
002772
CNE1000020B6
Fishing & Farming
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.34 CNY | +1.38% |
|
+3.67% | -6.97% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,415 | 2,541 | 4,247 | 3,406 | 3,269 | 3,103 |
| Enterprise Value (EV) 1 | 2,320 | 2,911 | 4,790 | 4,333 | 4,176 | 3,864 |
| P/E ratio | 21.6 x | 36.4 x | 20.6 x | 59.7 x | 20.8 x | 20.2 x |
| Yield | 1.55% | 1.45% | 0.87% | 1.2% | 3.61% | 3.8% |
| Capitalization / Revenue | 2.61 x | 2.2 x | 2.86 x | 2.19 x | 1.66 x | 1.61 x |
| EV / Revenue | 2.5 x | 2.52 x | 3.23 x | 2.78 x | 2.12 x | 2 x |
| EV / EBITDA | 10.4 x | 9.55 x | 11.3 x | 13.2 x | 8.04 x | 8.58 x |
| EV / FCF | -4.32 x | -6.46 x | -23.8 x | -5.49 x | 45.6 x | 17.5 x |
| FCF Yield | -23.1% | -15.5% | -4.19% | -18.2% | 2.19% | 5.7% |
| Price to Book | 0.92 x | 0.98 x | 1.56 x | 1.01 x | 0.97 x | 0.9 x |
| Nbr of stocks (in thousands) | 373,330 | 367,691 | 367,714 | 407,414 | 392,913 | 393,241 |
| Reference price 2 | 6.470 | 6.910 | 11.55 | 8.360 | 8.320 | 7.890 |
| Announcement Date | 19-03-29 | 20-04-28 | 21-03-25 | 22-03-23 | 23-03-20 | 24-03-25 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 926.4 | 1,156 | 1,483 | 1,556 | 1,970 | 1,931 |
| EBITDA 1 | 222.1 | 304.9 | 422.2 | 329.2 | 519.5 | 450.5 |
| EBIT 1 | 78.92 | 114.1 | 198.2 | 71.85 | 244.2 | 181.9 |
| Operating Margin | 8.52% | 9.88% | 13.36% | 4.62% | 12.39% | 9.42% |
| Earnings before Tax (EBT) 1 | 112.7 | 69.02 | 189.5 | 54.32 | 158.9 | 159.6 |
| Net income 1 | 111.9 | 68.4 | 189 | 54.97 | 158.4 | 159.6 |
| Net margin | 12.08% | 5.92% | 12.74% | 3.53% | 8.04% | 8.26% |
| EPS 2 | 0.3000 | 0.1900 | 0.5600 | 0.1400 | 0.4000 | 0.3900 |
| Free Cash Flow 1 | -536.4 | -450.6 | -201 | -789.2 | 91.5 | 220.2 |
| FCF margin | -57.9% | -38.98% | -13.55% | -50.71% | 4.64% | 11.4% |
| FCF Conversion (EBITDA) | - | - | - | - | 17.61% | 48.89% |
| FCF Conversion (Net income) | - | - | - | - | 57.78% | 138.01% |
| Dividend per Share 2 | 0.1000 | 0.1000 | 0.1000 | 0.1000 | 0.3000 | 0.3000 |
| Announcement Date | 19-03-29 | 20-04-28 | 21-03-25 | 22-03-23 | 23-03-20 | 24-03-25 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 371 | 543 | 927 | 907 | 761 |
| Net Cash position 1 | 95.9 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 1.216 x | 1.287 x | 2.817 x | 1.746 x | 1.689 x |
| Free Cash Flow 1 | -536 | -451 | -201 | -789 | 91.5 | 220 |
| ROE (net income / shareholders' equity) | 4.28% | 2.64% | 7.1% | 1.82% | 4.79% | 4.68% |
| ROA (Net income/ Total Assets) | 1.2% | 1.56% | 2.34% | 0.74% | 2.33% | 1.8% |
| Assets 1 | 9,307 | 4,373 | 8,082 | 7,427 | 6,806 | 8,875 |
| Book Value Per Share 2 | 7.050 | 7.070 | 7.420 | 8.270 | 8.610 | 8.730 |
| Cash Flow per Share 2 | 1.270 | 2.650 | 3.300 | 4.060 | 3.380 | 2.640 |
| Capex 1 | 652 | 664 | 380 | 286 | 246 | 107 |
| Capex / Sales | 70.34% | 57.41% | 25.6% | 18.41% | 12.48% | 5.54% |
| Announcement Date | 19-03-29 | 20-04-28 | 21-03-25 | 22-03-23 | 23-03-20 | 24-03-25 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.97% | 394M | |
| +18.09% | 1.03B | |
| +19.72% | 845M | |
| 0.00% | 780M | |
| -24.56% | 689M | |
| +3.46% | 368M | |
| -23.87% | 302M | |
| -25.42% | 268M | |
| -11.59% | 267M | |
| -12.75% | 261M |
- Stock Market
- Equities
- 002772 Stock
- Financials Tianshui Zhongxing Bio-technology Co.,Ltd.